RENE
Overvalued by 103.7% based on the discounted cash flow analysis.
Market cap | $247.99 Million |
---|---|
Enterprise Value | $247.91 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.41 |
Beta | -0.02 |
Outstanding Shares | 21,620,561 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 28.66 |
---|---|
PEG | -36.78 |
Price to Sales | - |
Price to Book Ratio | 3.92 |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | -245.74 |
Enterprise Value to Net Income | 39 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data